home » news and events » articles » Patent office practice: how Japan and Europe are responding to new trends in pharma research

Patent office practice: how Japan and Europe are responding to new trends in pharma research

Is a new administration regimen of a drug patentable or not? Patent offices must be prepared to answer this question, as the pharma industry focuses less on developing new molecules and more on the new uses of known medicaments. The article briefly describes what progress the Japanese and European patent offices have made on this matter.

Download full article (.pdf, 126 K)

 

Article based on:

Nobutaka Yokota, Japanese patent attorney with Kyowa Patent and Law Office, Japan: Patent eligibility expanded (first published in Life Sciences IP Focus 2009, Managing Intellectual Property).

Claudio Germinario, European patent attorney: unpublished material.